Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Multi-Omics Analysis of Human Mesenchymal Stem Cell Guides Perinatal MSC Based Cellular Therapy for Splenectomy-Nonresponsive Refractory Immune Thrombocytopenia: A Phase I Clinical Trial

Blood (2022) 140 (Supplement 1): 1974–1976.

DOI: https://doi.org/10.1182/blood-2022-156764

Published: 2022

Journal Articles

Hetrombopag Add to Porcine ATG and Cyclosporine for Aplastic Anemia: Early Outcomes of a Prospective Pilot Study

Wenrui Yang, Xin Zhao, Xu Liu, Youzhen Xiong, Huihui Fan, Guangxin Peng, Li Zhang, Jianping Li, Lei Ye, Kang Zhou, Yuan Li, Yang Yang, Yingchang Mi, Liping Jing, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 8663.

DOI: https://doi.org/10.1182/blood-2022-166616

Published: 2022

Journal Articles

Avatrombopag Added to Standard Immunosuppressive Therapy for Severe Aplastic Anemia

Xin Zhao, Baohang Zhang, Jianping Li, Huihui Fan, Yuan Li, Wenrui Yang, Liping Jing, Li Zhang, Kang Zhou, Youzhen Xiong, Lei Ye, Yingchang Mi, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 2940.

DOI: https://doi.org/10.1182/blood-2022-169378

Published: 2022

Journal Articles

Anti-Human T Lymphocyte Porcine Immunoglobulin Combined with Cyclosporine As First-Line Immunosuppressive Therapy for Severe Aplastic Anemia in China: A Large Single-Center, 10-Year Retrospective Study

Wenrui Yang, Xu Liu, Xin Zhao, Li Zhang, Guangxin Peng, Lei Ye, Kang Zhou, Yuan Li, Jianping Li, Huihui Fan, Yang Yang, Youzhen Xiong, Liping Jing, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 8655.

DOI: https://doi.org/10.1182/blood-2022-164574

Published: 2022

Journal Articles

Patient- and Clinician-Reported Performance Status in Patients with Multiple Myeloma Treated in the United States Using Real World Data

Vishal Bhatnagar, Bindu Kanapuru, Laura Fernandes, Ting-Yu Chen, Mallorie H. Fiero, Erica Horodniceanu, Nicole Gormley, Catherine Lerro, Fatima Rizvi, Yuan-Li Shen, Felice Yang, Anna Barcellos, Andrew J. Belli, Eric Hansen, Ching-Kun Wang, Donna Rivera, Paul Kluetz

Blood (2022) 140 (Supplement 1): 7156–7157.

DOI: https://doi.org/10.1182/blood-2022-166842

Published: 2022

Journal Articles

Predictive Factors of Relapse for Primary Immune Thrombocytopenia in Adults: A Single-Center Retrospective Cohort Analysis

Xiyan Wang, Xiaofan Liu, Yueshen Ma, Jiao Wang, Rongfeng Fu, Yunfei Chen, Wei Liu, Ting Sun, Mankai Ju, Hui Yuan Li, Feng Xue, Changping Li, Zhen Song, Lei Zhang, Renchi Yang

Blood (2022) 140 (Supplement 1): 2214–2215.

DOI: https://doi.org/10.1182/blood-2022-164457

Published: 2022

Journal Articles

Immunotyping of ITP Based on Different Platelet Destruction Mechanism Are Associated with Response to Splenectomy

Hui Yuan Li, Xueqing Dou, Yunfei Chen, Renchi Yang, Lei Zhang

Blood (2022) 140 (Supplement 1): 2211.

DOI: https://doi.org/10.1182/blood-2022-159829

Published: 2022

Journal Articles

Hematological Response to Avatrombopag Switch in Thrombopoietin Receptor Agonist-Refractory Aplastic Anemia

Liping Jing, Yingchang Mi, Huihui Fan, Wenrui Yang, Yuan Li, Jianping Li, Li Zhang, Xin Zhao, Kang Zhou, Lei Ye, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 5811–5812.

DOI: https://doi.org/10.1182/blood-2022-168380

Published: 2022

Journal Articles

Immunosuppressive Therapy-Response Predicting Scoring System for Severe Aplastic Anemia

Xin Zhao, Li Zhang, Bing Han, Tiantian Zhang, Xu Liu, Miao Chen, Changping Li, Huijie Huang, Liping Jing, Kang Zhou, Guangxin Peng, Yuan Li, Jianping Li, Lei Ye, Huihui Fan, Wenrui Yang, Yingchang Mi, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 5805–5806.

DOI: https://doi.org/10.1182/blood-2022-167951

Published: 2022

Journal Articles

Integrated Analysis of Key Genes for FGFR1 Knockdown in Mantle Cell Lymphoma Cell Line (Z-138)

Xue Wu, PhD, Yuan Li, PhD, Baoan Chen, MDPhD

Blood (2020) 136 (Supplement 1): 32.

DOI: https://doi.org/10.1182/blood-2020-143311

Published: 2020

Journal Articles

LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease Via Skewing T Cells Polarization Towards Treg Cells

Huihui Liu, PhD, Zhengyu Yu, MD, Bo Tang, MD, Shengchao Miao, MD, Chenchen Qin, Yuan Li, MD, Zeyin Liang, MD, Yang Zhang, Hanyun Ren, MD, Yujun Dong, MD

Blood (2020) 136 (Supplement 1): 4.

DOI: https://doi.org/10.1182/blood-2020-141877

Published: 2020

Journal Articles

An Accurate Prognostic Survival Model of Survival Based on Expression of Genes Involved in Plasma Cell Metabolism

Yang Liang, MD, Han-ying Huang, Yun Wang, MD PhD, Weida Wang, MD PhD, Jin-Yuan Li, Ling-ling Shu

Blood (2020) 136 (Supplement 1): 14–15.

DOI: https://doi.org/10.1182/blood-2020-140930

Published: 2020

Journal Articles

Paroxysmal Nocturnal Hemoglobinuria Clones Are Infrequent in Hepatitis-Associated Aplastic Anemia at the Time of Diagnosis

Wenrui Yang, MD, Xin Zhao, MD PhD, Guangxin Peng, MD, Li Zhang, MD, Liping Jing, MD, Kang Zhou, MD, Yang Li, MD, Lei Ye, MD, Yuan Li, MD, Jianping Li, MD, Huihui Fan, MD, Lin Song, MD, Yang Yang, MD, Youzhen Xiong, MD, Fengkui Zhang, MD, Jianxiang Wang, MD

Blood (2019) 134 (Supplement_1): 5016.

DOI: https://doi.org/10.1182/blood-2019-125620

Published: 2019

Journal Articles

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

Yuan Li, MD, Qing Ya Wang, MD, Ze Yin Liang, Yue Yin, Wei Liu, MD PhD, Qian Wang, Yujun Dong, MD, YuHua Sun, Wei Lin Xu, Hanyun Ren, MD PhD

Blood (2019) 134 (Supplement_1): 5647.

DOI: https://doi.org/10.1182/blood-2019-125275

Published: 2019

Journal Articles

FDA Analysis of Survival Outcomes in Older Adults with Relapsed-Refractory Multiple Myeloma (RRMM) Treated with Novel Drug Regimens

Bindu Kanapuru, MD, Susan Jin, Kunthel By, Theresa Carioti, Yuan-Li Shen, PhD, Rajeshwari Sridhara, PhD, Nicole J Gormley, MD, Ann T. Farrell, MD, Richard Pazdur, MD

Blood (2019) 134 (Supplement_1): 3194.

DOI: https://doi.org/10.1182/blood-2019-127141

Published: 2019

Journal Articles

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

Lu Zhang, Ai-lin Zhao, Ming-hui Duan, Zhi-yuan Li, Xin-xin Cao, Jun Feng, Dao-bin Zhou, Ding-rong Zhong, David C. Fajgenbaum, Jian Li

Blood (2019) 133 (16): 1720–1728.

DOI: https://doi.org/10.1182/blood-2018-11-884577

Published: 2019

Journal Articles

FDA Analysis of Outcomes in Older Adults with Relapsed or Refractory Multiple Myeloma

Bindu Kanapuru, MD, Susan Jin, Kunthel By, Yuan Li Shen, PhD, Theresa Carioti, Nicole Gormley, MD, Ann T. Farrell, MD, Richard Pazdur, MD

Blood (2018) 132 (Supplement 1): 3287.

DOI: https://doi.org/10.1182/blood-2018-99-118597

Published: 2018

Journal Articles

Response Rate, Event-Free Survival (EFS), and Overall Survival (OS) in Newly-Diagnosed Acute Myeloid Leukemia (AML): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

Kelly J. Norsworthy, MD, Xin Gao, PhD, Chia-Wen Ko, PhD, Jiaxi Zhou, MS, Yutao Gong, PhD, Yuan Li Shen, PhD, Rajeshwari Sridhara, PhD, Albert B. Deisseroth, MD PhD, Ann T. Farrell, MD, Richard Pazdur, MD, Gideon Blumenthal, MD

Blood (2018) 132 (Supplement 1): 2670.

DOI: https://doi.org/10.1182/blood-2018-99-119678

Published: 2018

Journal Articles

RNA:m 5 c/Methyltransferases Mediate Chromatin Organization and 5-Azacytidine Response/Resistance in Leukemia

Jason Cheng, MD PhD, Li Chen, PhD MD, Yuan Li, MD, Ming Yue, PhD, Adam Cloe, MD, PhD, Jamile M. Shammo, MD FASCP, FACP, Richard A. Larson, MD, Chuan He, PhD, Michelle M. Le Beau, PhD, James W. Vardiman, MD

Blood (2017) 130 (Supplement 1): 2471.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2471.2471

Published: 2017

Journal Articles

Wogonin As a Targeted Therapeutic Agent for EBV (+) Lymphoma Cells Involved in LMP1/NF-κB/Mir-155/PU.1 Pathway

Xue Wu, MD, Ping Liu, MD, Haijun ZHang, MDPhD, Yuan Li, MD, Jumah Masoud Mohammad Salmani, MDPhD, Fei Wang, MDPhD, Ke Yang, MD, Rong Fu, PhD, Baoan Chen, MDPhD, Zhewei Chen

Blood (2017) 130 (Supplement 1): 5204.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.5204.5204

Published: 2017

NARROW

Multi-Omics Analysis of Human Mesenchymal Stem Cell Guides Perinatal MSC Based Cellular Therapy for Splenectomy-Nonresponsive Refractory Immune Thrombocytopenia: A Phase I Clinical Trial

Hetrombopag Add to Porcine ATG and Cyclosporine for Aplastic Anemia: Early Outcomes of a Prospective Pilot Study

Avatrombopag Added to Standard Immunosuppressive Therapy for Severe Aplastic Anemia

Anti-Human T Lymphocyte Porcine Immunoglobulin Combined with Cyclosporine As First-Line Immunosuppressive Therapy for Severe Aplastic Anemia in China: A Large Single-Center, 10-Year Retrospective Study

Patient- and Clinician-Reported Performance Status in Patients with Multiple Myeloma Treated in the United States Using Real World Data

Predictive Factors of Relapse for Primary Immune Thrombocytopenia in Adults: A Single-Center Retrospective Cohort Analysis

Immunotyping of ITP Based on Different Platelet Destruction Mechanism Are Associated with Response to Splenectomy

Hematological Response to Avatrombopag Switch in Thrombopoietin Receptor Agonist-Refractory Aplastic Anemia

Immunosuppressive Therapy-Response Predicting Scoring System for Severe Aplastic Anemia

Integrated Analysis of Key Genes for FGFR1 Knockdown in Mantle Cell Lymphoma Cell Line (Z-138)

LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease Via Skewing T Cells Polarization Towards Treg Cells

An Accurate Prognostic Survival Model of Survival Based on Expression of Genes Involved in Plasma Cell Metabolism

Paroxysmal Nocturnal Hemoglobinuria Clones Are Infrequent in Hepatitis-Associated Aplastic Anemia at the Time of Diagnosis

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

FDA Analysis of Survival Outcomes in Older Adults with Relapsed-Refractory Multiple Myeloma (RRMM) Treated with Novel Drug Regimens

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

FDA Analysis of Outcomes in Older Adults with Relapsed or Refractory Multiple Myeloma

Response Rate, Event-Free Survival (EFS), and Overall Survival (OS) in Newly-Diagnosed Acute Myeloid Leukemia (AML): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

RNA:m 5 c/Methyltransferases Mediate Chromatin Organization and 5-Azacytidine Response/Resistance in Leukemia

Wogonin As a Targeted Therapeutic Agent for EBV (+) Lymphoma Cells Involved in LMP1/NF-κB/Mir-155/PU.1 Pathway

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only